Lymphoma Cancer

With breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) making recent headlines, many questions remain about this newly discovered illness.
 

From the Food and Drug Administration’s new clinical trial guidelines amid the COVID-19 pandemic to a mother meeting the cancer survivor who received her son’s heart 20 years after his passing, here’s what is making headlines in the cancer space this week.
 

Patients with relapsed and resistant diffuse large B-cell lymphoma can look to new treatments beyond tried-and-true chemotherapy.
 

ESPN sports reporter Edward Aschoff died because of undetected stage 4 non-Hodgkin's lymphoma— cancer detection methods need to change.

Here is a list of the recent trial initiations that occurred within the cancer space in December.

Real-world data shows that CAR-T therapy can lower costs for patients with pre-existing comorbidities outside of the clinical setting.
 

Some patients with non-Hodgkin lymphoma may soon have a treatment option that could offer complete remission, according to new data presented at the American Society of Hematology 2019 Annual Meeting.

An overview of the therapies available for patients with diffuse large B-cell lymphoma (DLBCL) and transformed follicular lymphoma.